Back
Canopy Growth Vs. Nova Mentis Life Science Industry Stock Comparison
Buy
57
WEED.TO
Canopy Growth
Last Price:
7.77
Seasonality Move:
22.78%
Sell
13
NOVA.CX
Nova Mentis Life Science
Last Price:
0.0100
Seasonality Move:
31.15%
Buy
57
Canopy Growth (WEED.TO)
is a Buy
Is Canopy Growth a Buy, Sell or Hold?
- The current Canopy Growth [WEED.TO] share price is $7.66. The Score for WEED.TO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- WEED.TO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
13
Nova Mentis Life Science (NOVA.CX)
is a Sell
Is Nova Mentis Life Science a Buy, Sell or Hold?
- The current Nova Mentis Life Science [NOVA.CX] share price is $0.0050. The Score for NOVA.CX is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- NOVA.CX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
WEED.TO Stock Price Chart
What is Canopy Growth's stock price today?
-
The Canopy Growth share price today is $7.66
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WEED.TO is experiencing slight buying pressure.
NOVA.CX Stock Price Chart
What is Nova Mentis Life Science's stock price today?
-
The Nova Mentis Life Science share price today is $0.0050
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NOVA.CX is experiencing slight buying pressure.
WEED.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 62.24 | Buy |
| Chaikin Money Flow: | 1086415 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.7 - 7.04) | Buy |
| Bollinger Bands (100): | (6.41 - 9.65) | Sell |
NOVA.CX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 40.31 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.0058 - 0.0058) | Sell |
| Bollinger Bands (100): | (0.0099 - 0.0099) | Sell |
WEED.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.11 | Buy |
| 20-day SMA: | 6.42 | Buy |
| 50-day SMA: | 6.57 | Buy |
| 200-day SMA: | 8.52 | Sell |
| 8-day EMA: | 6.99 | Buy |
| 20-day EMA: | 6.7 | Buy |
| 50-day EMA: | 6.96 | Buy |
| 200-day EMA: | 9.03 | Sell |
NOVA.CX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.01 | Sell |
| 20-day SMA: | 0.01 | Sell |
| 50-day SMA: | 0.01 | Sell |
| 200-day SMA: | 0.01 | Sell |
| 8-day EMA: | 0.01 | Sell |
| 20-day EMA: | 0.01 | Sell |
| 50-day EMA: | 0.01 | Sell |
| 200-day EMA: | 0.01 | Sell |
Canopy Growth Earnings Growth & WEED.TO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.12 per share, and an increase next year of $0.74 per share.
Nova Mentis Life Science Earnings Growth & NOVA.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Canopy Growth Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nova Mentis Life Science Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||